Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions.
George CN, Canuas-Landero V, Theodoulou E, Muthana M, Wilson C, Ottewell P. George CN, et al. Among authors: theodoulou e. J Bone Oncol. 2020 Sep 15;25:100317. doi: 10.1016/j.jbo.2020.100317. eCollection 2020 Dec. J Bone Oncol. 2020. PMID: 32995253 Free PMC article. Review.
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.
Collinson F, Royle KL, Swain J, Ralph C, Maraveyas A, Eisen T, Nathan P, Jones R, Meads D, Min Wah T, Martin A, Bestall J, Kelly-Morland C, Linsley C, Oughton J, Chan K, Theodoulou E, Arias-Pinilla G, Kwan A, Daverede L, Handforth C, Trainor S, Salawu A, McCabe C, Goh V, Buckley D, Hewison J, Gregory W, Selby P, Brown J, Brown J; all the STAR investigators. Collinson F, et al. Among authors: theodoulou e. Health Technol Assess. 2024 Aug;28(45):1-171. doi: 10.3310/JWTR4127. Health Technol Assess. 2024. PMID: 39250424 Free PMC article. Clinical Trial.